BC
VIR icon

BIT Capital’s Vir Biotechnology VIR Stock Holding History

BIT Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-40,000
Closed -$1.67M – 183
2021
Q4 		$1.67M Buy
+40,000
New +$1.57M 0.13% 62

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

BIT Capital's VIR Position: Q1 2026 in Review

BIT Capital opened a new position in Vir Biotechnology (VIR) in Q1 2026: 30,000 shares worth $269K. The stake represents 0.01% of the portfolio and ranks #84 among its holdings. This is a return to the name: BIT Capital previously reported a position in VIR as recently as Q1 2023.

BIT Capital first reported a position in VIR in Q4 2021 and has held it in 3 quarters since. The position peaked at $1.67M in Q4 2021. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • BIT Capital held 30,000 shares of Vir Biotechnology worth $269K as of Q1 2026.
  • Vir Biotechnology was a new BIT Capital position in Q1 2026.
  • Vir Biotechnology made up 0.01% of BIT Capital's portfolio in Q1 2026, its #84 holding.
  • BIT Capital first reported a position in Vir Biotechnology in Q4 2021 and has held it in 3 quarters since.
  • BIT Capital's Vir Biotechnology position peaked at $1.67M in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on BIT Capital's 13F filing for Q1 2026, filed 13 May 2026.